Head of Data Management beats his personal best in the 2006 London Marathon

Posted:
28
April 2006

Adam Walker, Head of Richmond's Data Management service completed the 2006 London Marathon in 4 hours and 24 minutes - his best time in 3 years.Richmond Pharmacology Ltd sponsored Adam £500 to complete the run and in total he has raised £3,000 for Bliss, the premature baby charity.Training for this year's run started in December 2005, although he did have his setbacks."In February I was admitted to hospital and was put on a drip for 2 days with a mystery illness this happened just 6 weeks before the marathon. Fortunately I made a rapid recovery and was able to resume training."Next year he aims to complete the course in under 4 hours!"By mile 20 I had a massive burst of energy and pushed on for the last 6 miles - sprinting to the finishing line!"The charity Bliss is dedicated to caring for premature babies: "This is the third consecutive year I have run to support Bliss and over the 3 years I have raised more than £10,000 for the charity. My daughter Amelie Grace was born 6 weeks prematurely and was in intensive care at the Sussex County Hospital, Brighton for 4 weeks. I am very grateful that Amelie was able to make a full recovery. I will continue to raise money for Bliss to help other families who find themselves in the same position"To find out more about Bliss visit: www.bliss.org.ukTo sponsor Adam, visit: www.justgiving.com/adamwalker_londonmarathon2006.

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more